{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:08:14Z","timestamp":1782835694230,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ganpo Elite Talents Support Program - Training Project for Academic and Technological Leaders in Major Disciplines"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-02185-x","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T04:06:59Z","timestamp":1764562019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Machine learning-driven glycolytic subtyping and exosome-based PKM splicing modulation overcome drug resistance in hyper-glycolytic myeloid leukemia"],"prefix":"10.1038","volume":"9","author":[{"given":"Fangmin","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2185_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41568-020-0260-3","volume":"20","author":"M Yamashita","year":"2020","unstructured":"Yamashita, M., Dellorusso, P. V., Olson, O. C. & Passegu\u00e9, E. Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis. Nat. Rev. Cancer 20, 365\u2013382 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2185_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 98, 502\u2013526 (2023).","journal-title":"Am. J. Hematol."},{"key":"2185_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N. Engl. J. Med. 373, 1136\u20131152 (2015).","journal-title":"N. Engl. J. Med."},{"key":"2185_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short, N. J. et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 10, 506\u2013525 (2020).","journal-title":"Cancer Discov."},{"key":"2185_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-00765-5","volume":"21","author":"F Thol","year":"2020","unstructured":"Thol, F. & Ganser, A. Treatment of relapsed acute myeloid leukemia. Curr. Treat. options Oncol. 21, 66 (2020).","journal-title":"Curr. Treat. options Oncol."},{"key":"2185_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00001622-200111000-00008","volume":"13","author":"JP Marie","year":"2001","unstructured":"Marie, J. P. Drug resistance in hematologic malignancies. Curr. Opin. Oncol. 13, 463\u2013469 (2001).","journal-title":"Curr. Opin. Oncol."},{"key":"2185_CR7","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","volume":"1","author":"BM Stevens","year":"2020","unstructured":"Stevens, B. M. et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat. Cancer 1, 1176\u20131187 (2020).","journal-title":"Nat. Cancer"},{"key":"2185_CR8","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/OTT.S191621","volume":"12","author":"J Zhang","year":"2019","unstructured":"Zhang, J., Gu, Y. & Chen, B. Mechanisms of drug resistance in acute myeloid leukemia. Onco Targets Ther. 12, 1937\u20131945 (2019).","journal-title":"Onco Targets Ther."},{"key":"2185_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674, https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"2185_CR10","doi-asserted-by":"publisher","unstructured":"Fukushi, A., Kim, H. D., Chang, Y. C. & Kim, C. H. Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells. Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms231710037 (2022).","DOI":"10.3390\/ijms231710037"},{"key":"2185_CR11","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel, P., Schmidberger, H. & Mayer, A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int. J. Radiat. Biol. 95, 912\u2013919 (2019).","journal-title":"Int. J. Radiat. Biol."},{"key":"2185_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P Icard","year":"2018","unstructured":"Icard, P. et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells?. Drug Resist. Updates 38, 1\u201311 (2018).","journal-title":"Drug Resist. Updates"},{"key":"2185_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/ol.2016.4600","volume":"12","author":"K Song","year":"2016","unstructured":"Song, K. et al. Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia. Oncol. Lett. 12, 334\u2013342 (2016).","journal-title":"Oncol. Lett."},{"key":"2185_CR14","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3324\/haematol.2020.246843","volume":"106","author":"H \u00c5backa","year":"2021","unstructured":"\u00c5backa, H. et al. Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance. Haematologica 106, 1163\u20131166 (2021).","journal-title":"Haematologica"},{"key":"2185_CR15","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1002\/jcb.26899","volume":"119","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Liu, Y. & Xu, X. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a\/hexokinase 2 pathway. J. Cell Biochem. 119, 6296\u20136308 (2018).","journal-title":"J. Cell Biochem."},{"key":"2185_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108244","volume":"680","author":"L Chen","year":"2020","unstructured":"Chen, L., Hu, N., Wang, C. & Zhao, H. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt\/\u03b2-catenin\/PFKP pathway in acute myeloid leukemia cells. Arch. Biochem. Biophys. 680, 108244 (2020).","journal-title":"Arch. Biochem. Biophys."},{"key":"2185_CR17","doi-asserted-by":"publisher","first-page":"10897","DOI":"10.1039\/C9RA00306A","volume":"9","author":"L Chen","year":"2019","unstructured":"Chen, L., Zhao, H., Wang, C. & Hu, N. TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60\/ADR cells. RSC Adv. 9, 10897\u201310904 (2019).","journal-title":"RSC Adv."},{"key":"2185_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/hon.2834","volume":"39","author":"V Mpakou","year":"2021","unstructured":"Mpakou, V. et al. Upregulated hypoxia inducible factor 1\u03b1 signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group. Hematol. Oncol. 39, 231\u2013242 (2021).","journal-title":"Hematol. Oncol."},{"key":"2185_CR19","doi-asserted-by":"publisher","first-page":"13807","DOI":"10.1016\/S0021-9258(18)67091-7","volume":"261","author":"T Noguchi","year":"1986","unstructured":"Noguchi, T., Inoue, H. & Tanaka, T. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J. Biol. Chem. 261, 13807\u201313812 (1986).","journal-title":"J. Biol. Chem."},{"key":"2185_CR20","doi-asserted-by":"publisher","first-page":"ra73","DOI":"10.1126\/scisignal.2000431","volume":"2","author":"T Hitosugi","year":"2009","unstructured":"Hitosugi, T. et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2, ra73 (2009).","journal-title":"Sci. Signal."},{"key":"2185_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20111487","volume":"209","author":"MS Goldberg","year":"2012","unstructured":"Goldberg, M. S. & Sharp, P. A. Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression. J. Exp. Med. 209, 217\u2013224 (2012).","journal-title":"J. Exp. Med."},{"key":"2185_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molcel.2014.10.027","volume":"57","author":"SY Lunt","year":"2015","unstructured":"Lunt, S. Y. et al. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol. Cell 57, 95\u2013107 (2015).","journal-title":"Mol. Cell"},{"key":"2185_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230\u2013233 (2008).","journal-title":"Nature"},{"key":"2185_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","volume":"29","author":"H Xie","year":"2022","unstructured":"Xie, H., Yao, J., Wang, Y. & Ni, B. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis. Drug Deliv. 29, 1257\u20131271 (2022).","journal-title":"Drug Deliv."},{"key":"2185_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct. Target. Ther. 8, 124 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2185_CR26","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1182\/blood-2012-12-475194","volume":"123","author":"E Nievergall","year":"2014","unstructured":"Nievergall, E. et al. Monoclonal antibody targeting of IL-3 receptor \u03b1 with CSL362 effectively depletes CML progenitor and stem cells. Blood 123, 1218\u20131228 (2014).","journal-title":"Blood"},{"key":"2185_CR27","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","volume":"100","author":"U Testa","year":"2002","unstructured":"Testa, U. et al. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 100, 2980\u20132988 (2002).","journal-title":"Blood"},{"key":"2185_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-2-4","volume":"2","author":"U Testa","year":"2014","unstructured":"Testa, U., Pelosi, E. & Frankel, A. CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies. Biomark. Res. 2, 4 (2014).","journal-title":"Biomark. Res."},{"key":"2185_CR29","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.7150\/thno.17092","volume":"7","author":"D Bellavia","year":"2017","unstructured":"Bellavia, D. et al. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. Theranostics 7, 1333\u20131345 (2017).","journal-title":"Theranostics"},{"key":"2185_CR30","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul, S., Ghosh, S. & Kumar, S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 86, 1216\u20131230 (2022).","journal-title":"Semin Cancer Biol."},{"key":"2185_CR31","doi-asserted-by":"publisher","unstructured":"Chelakkot, C., Chelakkot, V. S., Shin, Y. & Song, K. Modulating glycolysis to improve cancer therapy. Int. J. Mol. Sci. 24, https:\/\/doi.org\/10.3390\/ijms24032606 (2023).","DOI":"10.3390\/ijms24032606"},{"key":"2185_CR32","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1182\/blood-2014-02-554204","volume":"124","author":"WL Chen","year":"2014","unstructured":"Chen, W. L. et al. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood 124, 1645\u20131654 (2014).","journal-title":"Blood"},{"key":"2185_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35721","volume":"10","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Pu, J. & Yang, Y. Glycolysis and chemoresistance in acute myeloid leukemia. Heliyon 10, e35721 (2024).","journal-title":"Heliyon"},{"key":"2185_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215997","volume":"554","author":"H Zhou","year":"2023","unstructured":"Zhou, H. et al. Therapeutic inhibition of PPAR\u03b1-HIF1\u03b1-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia. Cancer Lett. 554, 215997 (2023).","journal-title":"Cancer Lett."},{"key":"2185_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109094","volume":"242","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1\u03b1 expression. Clin. Immunol. 242, 109094 (2022).","journal-title":"Clin. Immunol."},{"key":"2185_CR36","first-page":"999","volume":"43","author":"P Ma","year":"2020","unstructured":"Ma, P. et al. High PD\u2011L1 expression drives glycolysis via an Akt\/mTOR\/HIF\u20111\u03b1 axis in acute myeloid leukemia. Oncol. Rep. 43, 999\u20131009 (2020).","journal-title":"Oncol. Rep."},{"key":"2185_CR37","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1038\/onc.2010.67","volume":"29","author":"F Zhao","year":"2010","unstructured":"Zhao, F. et al. Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene 29, 2962\u20132972 (2010).","journal-title":"Oncogene"},{"key":"2185_CR38","doi-asserted-by":"publisher","unstructured":"Luo, Y., Wang, X., Shen, J. & Yao, J. Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review). Int. J. Oncol. 59, https:\/\/doi.org\/10.3892\/ijo.2021.5242 (2021).","DOI":"10.3892\/ijo.2021.5242"},{"key":"2185_CR39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3109\/10428194.2011.565437","volume":"52","author":"I Shachar","year":"2011","unstructured":"Shachar, I. & Haran, M. The secret second life of an innocent chaperone: the story of CD74 and B cell\/chronic lymphocytic leukemia cell survival. Leuk. Lymphoma 52, 1446\u20131454 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"2185_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12032-015-0650-7","volume":"32","author":"JW Lu","year":"2015","unstructured":"Lu, J. W. et al. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine. Med. Oncol. 32, 206 (2015).","journal-title":"Med. Oncol."},{"key":"2185_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1182\/blood-2004-09-3523","volume":"106","author":"RA Mesa","year":"2005","unstructured":"Mesa, R. A. et al. Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine. Blood 106, 318\u2013327 (2005).","journal-title":"Blood"},{"key":"2185_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116065","volume":"228","author":"J Zhao","year":"2024","unstructured":"Zhao, J. et al. Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax. Biochem. Pharmacol. 228, 116065 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"2185_CR43","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1158\/1078-0432.CCR-19-0171","volume":"25","author":"MJ Wieduwilt","year":"2019","unstructured":"Wieduwilt, M. J. et al. Histone deacetylase inhibition with panobinostat combined with intensive induction chemotherapy in older patients with acute myeloid leukemia: Phase I study results. Clin. Cancer Res. 25, 4917\u20134923 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2185_CR44","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/leu.2017.45","volume":"31","author":"HQ Ju","year":"2017","unstructured":"Ju, H. Q. et al. ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition. Leukemia 31, 2143\u20132150 (2017).","journal-title":"Leukemia"},{"key":"2185_CR45","doi-asserted-by":"publisher","unstructured":"Li, Y. et al. The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation. Mol. Oncol. https:\/\/doi.org\/10.1002\/1878-0261.70090 (2025).","DOI":"10.1002\/1878-0261.70090"},{"key":"2185_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.120009","volume":"1872","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. PGK1 mediates glycolysis and cell proliferation in endometriosis by regulating DDIT4 nuclear translocation. Biochim. Biophys. Acta Mol. Cell Res. 1872, 120009 (2025).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"2185_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.833797","volume":"13","author":"A Jiang","year":"2022","unstructured":"Jiang, A. et al. Integration of single-cell RNA sequencing and bulk RNA sequencing data to establish and validate a prognostic model for patients with lung adenocarcinoma. Front. Genet. 13, 833797 (2022).","journal-title":"Front. Genet."},{"key":"2185_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30972-7","volume":"13","author":"H Zheng","year":"2023","unstructured":"Zheng, H., Li, Y., Zhao, Y. & Jiang, A. Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma. Sci. Rep. 13, 3684 (2023).","journal-title":"Sci. Rep."},{"key":"2185_CR49","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen, P. et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265\u20131281.e1224 (2019).","journal-title":"Cell"},{"key":"2185_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"2185_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"2185_CR52","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"A Newman","year":"2015","unstructured":"Newman, A. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"2185_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12, 21 (2020).","journal-title":"Genome Med."},{"key":"2185_CR54","doi-asserted-by":"crossref","unstructured":"Min, Q. H. et al. Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365. Exp Cell Res. 362, 386\u2013393 (2018).","DOI":"10.1016\/j.yexcr.2017.12.001"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02185-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:03:46Z","timestamp":1767801826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02185-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2185"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02185-x","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}